Skip to content

GLUCOSE HEALTH, INC.: 10-Q/A filed 2011-09-28

What GLUCOSE HEALTH, INC. reported in its quarterly report amendment filed 2011-09-28 (fiscal Q2 2011): 17 published measures, 35 facts as tagged in accession 0001096350-11-000145.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2011-09-28
Fiscal period
fiscal Q2 2011
Accession
0001096350-11-000145 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GLUCOSE HEALTH, INC. filings.

Reported measures

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2010-12-31682,364USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2010-12-31-614,304USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-01-30 to 2011-06-30-567,877USD152
2010-01-30 to 2010-06-30-427,988USD152

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-30 to 2011-06-30-13,840USD152
2010-01-30 to 2010-06-30-96,050USD152

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-30 to 2011-06-3014,662USD152
2010-01-30 to 2010-06-3099,180USD152

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2010-12-31-2,144,311USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-04-30 to 2011-06-3026,453,408shares62
2011-01-31 to 2011-06-3023,110,903shares151
2010-04-30 to 2010-06-3017,833,236shares62
2010-01-31 to 2010-06-3017,476,562shares151

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2010-12-3187,791USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-04-30 to 2011-06-30-5,342USD62
2011-01-31 to 2011-06-30-10,537USD151
2010-04-30 to 2010-06-30-3,150USD62
2010-01-31 to 2010-06-30-6,058USD151

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2010-12-31682,364USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-30 to 2011-06-30453,653USD62
2011-01-31 to 2011-06-30560,098USD151
2010-04-30 to 2010-06-30155,350USD62
2010-01-31 to 2010-06-30421,930USD151

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2010-12-3187,758USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-04-30 to 2011-06-30698USD62
2011-01-31 to 2011-06-302,758USD151

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2011-04-30 to 2011-06-30-698USD62
2011-01-31 to 2011-06-30-2,758USD151

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2010-12-311,598,026USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-30 to 2011-06-304,763USD62
2011-01-31 to 2011-06-309,823USD151
2010-04-30 to 2010-06-3021,505USD62
2010-01-31 to 2010-06-3049,633USD151

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-30 to 2011-06-3093,920USD152
2010-01-30 to 2010-06-3060,846USD152

Inspect the source

Entity
GLUCOSE HEALTH, INC. / CIK 0001420108
Captured
2026-09-20T08:03:02.532Z
SEC response SHA-256
ef83fc563a3cad26f7c669ccda854bb2594ebf064cf3fcc8412c49070ba2bb26

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001420108.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))